(Q72112429)

English

Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer

scientific article published on 01 April 1995

Statements

Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit